Clinical Analytics Companies

The clinical analytics market is projected to reach USD 81.32 billion by 2030 from USD 33.09 billion in 2025, at a CAGR of 19.7% during the forecast period. The growth of the clinical analytics market is primarily driven by the shift toward value-based care and reimbursement models, pushing healthcare organizations to enhance outcomes while reducing costs. Increasing regulatory openness to real-world evidence (RWE) is fostering the integration of advanced analytics into clinical and research workflows. Additionally, the rapid adoption of cloud-based and modern data platforms, enabling scalable, real-time insights and seamless interoperability, further accelerates market expansion.

Leading companies in the market for clinical analytics include Optum, Inc. (UnitedHealth Group) (US), Epic Systems Corporation (US), GE HealthCare (US), Siemens Healthineers (Germany), Oracle (US), McKesson Corporation (US), Veradigm LLC (US), IQVIA (US). These organizations have adopted a mix of inorganic and organic growth strategies, including partnerships, agreements, product launches, acquisitions, expansions, and collaborations.

To know about the assumptions considered for the study download the pdf brochure

In September 2025, Epic launched Comet, a medical intelligence platform designed to deliver advanced clinical and operational insights. Comet integrates data across multiple systems, using AI and real-time analytics to support clinical decision-making, operational forecasting, and population health management. It enables proactive identification of trends and resource needs, improving efficiency and patient outcomes.

In August 2025, IQVIA entered long-term clinical and commercial partnerships with Veeva Systems to integrate IQVIA’s data and analytics with Veeva’s commercial platforms. The collaboration focuses on improving trial planning, execution, and commercial operations, enhancing operational efficiency, and supporting real-time clinical and commercial insights.

Optum Inc is a leading provider of healthcare data and analytics solutions, leveraging its extensive real-world data assets and AI-driven platforms to deliver insights across payers, providers, and life sciences organizations. Through its Optum Insight division, the company integrates clinical, claims, and genomic data to support value-based care, predictive analytics, and real-world evidence generation. Optum’s strategic acquisitions, including Change Healthcare, have strengthened its data interoperability and analytics capabilities, enabling seamless integration across the healthcare ecosystem. Its vertically integrated structure—spanning care delivery, insurance, and analytics—positions Optum as a comprehensive player in the clinical analytics market, offering scalable, data-driven solutions for improving outcomes, optimizing workflows, and advancing evidence-based decision-making.

IQVIA is a global leader in clinical data and advanced analytics, providing AI-powered platforms that streamline clinical trial operations and data management. Its Clinical Data Analytics Suite (CDAS) enables real-time data integration, visualization, and predictive modeling across structured and unstructured sources, helping sponsors and CROs accelerate study timelines and enhance oversight. IQVIA’s deep domain expertise in clinical research, combined with its vast global data network, supports analytics for trial design, site selection, and patient recruitment. With a focus on automation, efficiency, and regulatory compliance, IQVIA remains a key innovator in clinical analytics, driving digital transformation across the life sciences value chain.

Oracle has emerged as a major force in healthcare and life sciences analytics through its cloud-based infrastructure and integrated data intelligence platforms. Following its acquisition of Cerner, Oracle expanded its reach into clinical and EHR data management, enabling end-to-end analytics across research, care delivery, and population health. Its Oracle Analytics Intelligence for Life Sciences and Clinical Development Analytics solutions leverage AI and machine learning to unify data, ensure compliance, and accelerate clinical insights. With strong capabilities in data integration, scalability, and value-based health analytics, Oracle offers a robust ecosystem for organizations seeking enterprise-grade clinical analytics solutions built on secure and interoperable cloud architecture.

Market Ranking

The clinical analytics market is moderately fragmented but highly competitive, with global leaders such as Optum, Epic Systems, GE Healthcare, Siemens Healthineers, and Oracle Health Sciences driving large-scale solutions for population health management, predictive modelling, and precision medicine. Key players such as IQVIA, Athenahealth, Veeva Systems, and Health Catalyst focus on real-world evidence, interoperability, and advanced analytics, while companies such as Accenture, CVS Health, and eClinicalWorks enable workflow optimization and value-based care. Emerging firms, including Apriqot, Oler Health, and Ferrum Health, offer specialized solutions for imaging analytics and compliance. Increasing competition is pushing vendors to leverage AI-driven insights, cloud-based platforms, and regulatory-ready tools to improve outcomes and accelerate the shift toward value-based healthcare.

Related Reports:

Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com